ElevateBio
Waltham · Founded 2017
About ElevateBio
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $1.2B
- Funding stage: Late Stage Venture
- Last round: Series D (May 2023)
- Website: elevate.bio
- Phone: +1 617 433 2600
Industries & Categories
Alternative Medicine, Biotechnology, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/elevatebio-123966 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.